[#item_full_content] A major M&A offer is on the table, giving Aurora shareholders a 51% premium and the chance to participate in a global cannabis leader’s growth. The deal leverages Curaleaf’s scale, financial strength, and operational expertise, while criticizing Aurora’s ongoing decline and lack of engagement.Based…
Read More
CURA: Aurora shareholders are offered a 51% premium and entry into a global cannabis leader’s growth